GR1009632B - Διατροφικο συμπληρωμα για την απο του στοματος χορηγηση συνδυασμου λακτοφερινης, ξυλογλυκανης, προανθοκυανιδινων και σιμεθικονης, χρησιμων για την προληψη λοιμωξεων του γαστρεντερικου και ουροποιητικου συστηματος - Google Patents

Διατροφικο συμπληρωμα για την απο του στοματος χορηγηση συνδυασμου λακτοφερινης, ξυλογλυκανης, προανθοκυανιδινων και σιμεθικονης, χρησιμων για την προληψη λοιμωξεων του γαστρεντερικου και ουροποιητικου συστηματος

Info

Publication number
GR1009632B
GR1009632B GR20180100307A GR20180100307A GR1009632B GR 1009632 B GR1009632 B GR 1009632B GR 20180100307 A GR20180100307 A GR 20180100307A GR 20180100307 A GR20180100307 A GR 20180100307A GR 1009632 B GR1009632 B GR 1009632B
Authority
GR
Greece
Prior art keywords
xyloglucan
lactoferrin
simethicone
proanthocyanidin
gastrointestinal
Prior art date
Application number
GR20180100307A
Other languages
English (en)
Inventor
Ιουλια Κλεωνος Τσετη
Original Assignee
Ιουλια Κλεωνος Τσετη
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ιουλια Κλεωνος Τσετη filed Critical Ιουλια Κλεωνος Τσετη
Priority to GR20180100307A priority Critical patent/GR1009632B/el
Priority to ES19749778T priority patent/ES2928471T3/es
Priority to DK19749778.7T priority patent/DK3820466T3/da
Priority to PCT/GR2019/000049 priority patent/WO2020012203A1/en
Priority to EP19749778.7A priority patent/EP3820466B1/en
Priority to PT197497787T priority patent/PT3820466T/pt
Publication of GR1009632B publication Critical patent/GR1009632B/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/40—Transferrins, e.g. lactoferrins, ovotransferrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/80—Polymers containing hetero atoms not provided for in groups A61K31/755 - A61K31/795
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/45—Ericaceae or Vacciniaceae (Heath or Blueberry family), e.g. blueberry, cranberry or bilberry
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/46—Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D51/00—Closures not otherwise provided for
    • B65D51/24—Closures not otherwise provided for combined or co-operating with auxiliary devices for non-closing purposes
    • B65D51/28—Closures not otherwise provided for combined or co-operating with auxiliary devices for non-closing purposes with auxiliary containers for additional articles or materials
    • B65D51/2807—Closures not otherwise provided for combined or co-operating with auxiliary devices for non-closing purposes with auxiliary containers for additional articles or materials the closure presenting means for placing the additional articles or materials in contact with the main contents by acting on a part of the closure without removing the closure, e.g. by pushing down, pulling up, rotating or turning a part of the closure, or upon initial opening of the container
    • B65D51/2814—Closures not otherwise provided for combined or co-operating with auxiliary devices for non-closing purposes with auxiliary containers for additional articles or materials the closure presenting means for placing the additional articles or materials in contact with the main contents by acting on a part of the closure without removing the closure, e.g. by pushing down, pulling up, rotating or turning a part of the closure, or upon initial opening of the container the additional article or materials being released by piercing, cutting or tearing an element enclosing it
    • B65D51/2828—Closures not otherwise provided for combined or co-operating with auxiliary devices for non-closing purposes with auxiliary containers for additional articles or materials the closure presenting means for placing the additional articles or materials in contact with the main contents by acting on a part of the closure without removing the closure, e.g. by pushing down, pulling up, rotating or turning a part of the closure, or upon initial opening of the container the additional article or materials being released by piercing, cutting or tearing an element enclosing it said element being a film or a foil
    • B65D51/2835—Closures not otherwise provided for combined or co-operating with auxiliary devices for non-closing purposes with auxiliary containers for additional articles or materials the closure presenting means for placing the additional articles or materials in contact with the main contents by acting on a part of the closure without removing the closure, e.g. by pushing down, pulling up, rotating or turning a part of the closure, or upon initial opening of the container the additional article or materials being released by piercing, cutting or tearing an element enclosing it said element being a film or a foil ruptured by a sharp element, e.g. a cutter or a piercer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Botany (AREA)
  • Inorganic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medical Informatics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Dispersion Chemistry (AREA)
  • Mechanical Engineering (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Διατροφικό συμπλήρωμα, σε μορφή πόσιμου εναιωρήματος μίας δόσης, το οποίο περιέχει ως δραστικά συστατικά λακτοφερίνη, ξυλογλυκάνη, προανθοκυανιδίνες και σιμεθικόνη, χρήσιμο για την πρόληψη των λοιμώξεων του γαστρεντερικού και του ουροποιητικού συστήματος. Τα συστατικά του διατροφικού συμπληρώματος φυλάσσονται σε μία διάταξη πώματος με αποθηκευτικό χώρο και φιαλίδιο, όπου το πώμα με τον αποθηκευτικό χώρο περιέχει μία σύνθεση σε μορφή σκόνης που βασίζεται σε λακτοφερίνη, ξυλογλυκάνη και εκχύλισμα κράνμπερι, το δε φιαλίδιο περιέχει ένα αρωματισμένο εναιώρημα σιμεθικόνης. Η στερεή κονιοποιημένη σύνθεση λακτοφερίνης, ξυλογλυκάνης και εκχυλίσματος κράμπερι που περιέχεται στο πώμα με τον αποθηκευτικό χώρο, αναμειγνύεται με το αρωματισμένο εναιώρημα σιμεθικόνης που περιέχεται στο φιαλίδιο, μέσω διαδικασίας ενός σταδίου ακριβώς πριν από τη στιγμή της χρήσης και οδηγεί σε ένα πόσιμο εύγεστο εναιώρημα που μπορεί να καταναλωθεί άμεσα από το φιαλίδιο.
GR20180100307A 2018-07-09 2018-07-09 Διατροφικο συμπληρωμα για την απο του στοματος χορηγηση συνδυασμου λακτοφερινης, ξυλογλυκανης, προανθοκυανιδινων και σιμεθικονης, χρησιμων για την προληψη λοιμωξεων του γαστρεντερικου και ουροποιητικου συστηματος GR1009632B (el)

Priority Applications (6)

Application Number Priority Date Filing Date Title
GR20180100307A GR1009632B (el) 2018-07-09 2018-07-09 Διατροφικο συμπληρωμα για την απο του στοματος χορηγηση συνδυασμου λακτοφερινης, ξυλογλυκανης, προανθοκυανιδινων και σιμεθικονης, χρησιμων για την προληψη λοιμωξεων του γαστρεντερικου και ουροποιητικου συστηματος
ES19749778T ES2928471T3 (es) 2018-07-09 2019-07-05 Suplemento nutricional, apto para administración oral, que comprende lactoferrina, xiloglucano, proantocianidinas y simeticona para la prevención conjunta de infecciones del tracto gastrointestinal y urinario
DK19749778.7T DK3820466T3 (da) 2018-07-09 2019-07-05 Kosttilskud, egnet til oral indgivelse, omfattende lactoferrin, xyloglucan, proanthocyanidiner og simethicon til samlet forebyggelse af mave-tarmkanal- og urinvejsinfektioner
PCT/GR2019/000049 WO2020012203A1 (en) 2018-07-09 2019-07-05 Nutritional supplement,suitable for oral administration,comprising lactoferrin,xyloglucan,proanthocyanidins and simethicone for the joint prevention of gastroinntestinal and urinary tract infections
EP19749778.7A EP3820466B1 (en) 2018-07-09 2019-07-05 Nutritional supplement, suitable for oral administration, comprising lactoferrin, xyloglucan, proanthocyanidins and simethicone for the joint prevention of gastrointestinal and urinary tract infections
PT197497787T PT3820466T (pt) 2018-07-09 2019-07-05 Suplemento nutricional, adequado para administração oral, compreendendo lactoferrina, xiloglucano, proantocianidinas e simeticone para a prevenção conjunta de infeções gastrintestinais e urinárias

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GR20180100307A GR1009632B (el) 2018-07-09 2018-07-09 Διατροφικο συμπληρωμα για την απο του στοματος χορηγηση συνδυασμου λακτοφερινης, ξυλογλυκανης, προανθοκυανιδινων και σιμεθικονης, χρησιμων για την προληψη λοιμωξεων του γαστρεντερικου και ουροποιητικου συστηματος

Publications (1)

Publication Number Publication Date
GR1009632B true GR1009632B (el) 2019-10-25

Family

ID=67544272

Family Applications (1)

Application Number Title Priority Date Filing Date
GR20180100307A GR1009632B (el) 2018-07-09 2018-07-09 Διατροφικο συμπληρωμα για την απο του στοματος χορηγηση συνδυασμου λακτοφερινης, ξυλογλυκανης, προανθοκυανιδινων και σιμεθικονης, χρησιμων για την προληψη λοιμωξεων του γαστρεντερικου και ουροποιητικου συστηματος

Country Status (6)

Country Link
EP (1) EP3820466B1 (el)
DK (1) DK3820466T3 (el)
ES (1) ES2928471T3 (el)
GR (1) GR1009632B (el)
PT (1) PT3820466T (el)
WO (1) WO2020012203A1 (el)

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0990438A1 (en) * 1998-09-21 2000-04-05 McNEIL-PPC, INC. Heat stable antacid and antigas suspensions
US20060269535A1 (en) * 2005-05-31 2006-11-30 Naidu A S Metallo-lactoferrin-coenzyme compositions for trigger and release of bioenergy
WO2008018111A2 (en) * 2006-08-09 2008-02-14 Opocrin S.P.A. Composition containing cranberry (vaccinium macrocarpon) and lactoferrin for the prevention and treatment of urinary tract infections
WO2015158771A1 (en) * 2014-04-15 2015-10-22 Novintethical Pharma Sa Compositions based on xyloglucan and proteins for the treatment of intestinal disorders
US20160317388A1 (en) * 2014-05-01 2016-11-03 Sun Pharmaceutical Industries Limited Dual-chamber pack for extended release suspension compositions
US20180093803A1 (en) * 2016-10-05 2018-04-05 Mead Johnson Nutrition Company Container closure with compartment

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR1002332B (el) * 1992-05-21 1996-05-16 Mcneil-Ppc Inc. Νεες φαρμακευτικες συνθεσεις που περιεχουν σιμεθεικονη.
EP0904784A1 (en) * 1997-09-22 1999-03-31 N.V. Nutricia Probiotic nutritional preparation
US6231866B1 (en) * 1998-04-30 2001-05-15 Douglas G. Mann Infused vegetable, fruit, herb, and/or seed fiber product and dietary supplements containing same
ITMI20041577A1 (it) 2004-07-30 2004-10-30 Inge Spa Dispositivo di chiusura con camera per un contenitore di sostanze da mantenersi separate fino all'erogazione
US9314494B2 (en) * 2012-05-25 2016-04-19 The United States Of America, As Represented By The Secretary Of Agriculture Cranberry xyloglucan oligosaccharide composition
ITTO20120506A1 (it) 2012-06-12 2013-12-13 Inge Spa Cappuccio per un flacone atto alla conservazione di sostanze da mantenersi separate fino alla loro applicazione.
ITTO20121006A1 (it) 2012-11-20 2014-05-21 Inge Spa Dispositivo per la conservazione ermetica di una sostanza da miscelare ad un'altra contenuta in un contenitore.
US20140255365A1 (en) 2013-03-11 2014-09-11 Mead Johnson Nutrition Company Oral Electrolyte Solution Containing Lactoferrin and Uses Thereof
US20150094266A1 (en) * 2013-06-11 2015-04-02 Novintethical Pharma, SA Xyloglucan and protein compositions for the treatment of intestinal disorders

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0990438A1 (en) * 1998-09-21 2000-04-05 McNEIL-PPC, INC. Heat stable antacid and antigas suspensions
US20060269535A1 (en) * 2005-05-31 2006-11-30 Naidu A S Metallo-lactoferrin-coenzyme compositions for trigger and release of bioenergy
WO2008018111A2 (en) * 2006-08-09 2008-02-14 Opocrin S.P.A. Composition containing cranberry (vaccinium macrocarpon) and lactoferrin for the prevention and treatment of urinary tract infections
WO2015158771A1 (en) * 2014-04-15 2015-10-22 Novintethical Pharma Sa Compositions based on xyloglucan and proteins for the treatment of intestinal disorders
US20160317388A1 (en) * 2014-05-01 2016-11-03 Sun Pharmaceutical Industries Limited Dual-chamber pack for extended release suspension compositions
US20180093803A1 (en) * 2016-10-05 2018-04-05 Mead Johnson Nutrition Company Container closure with compartment

Also Published As

Publication number Publication date
DK3820466T3 (da) 2022-10-17
PT3820466T (pt) 2022-10-21
ES2928471T3 (es) 2022-11-18
EP3820466B1 (en) 2022-09-07
EP3820466A1 (en) 2021-05-19
WO2020012203A1 (en) 2020-01-16

Similar Documents

Publication Publication Date Title
NZ712270A (en) Pharmaceutical composition of s-ketamine hydrochloride
MX362807B (es) Formulacion estabilizada de pemetrexed.
CR20130244S (es) Tapa para contenedor
EA201390409A1 (ru) Составы с низкой дозой панкрелипазы и кишечно-растворимым покрытием
HRP20151337T1 (hr) Farmaceutski oblik doziranja koji sadrži 6'-fluoro-(n-metil- ili n,n-dimetil)-4-fenil-4',9'-dihidro-3'h-spiro[cikloheksan-1,1'-pirano[3,4,b]indol]-4-amin
MX2009009997A (es) Preparacion de la capsula de tamibarotene.
NZ702342A (en) Pharmaceutical formulation
MX368543B (es) Composiciones para tratar diarrea inducida por rotavirus.
EA201300539A1 (ru) Твердая композиция для приема внутрь (варианты), способ терапевтической или нетерапевтической профилактики желудочно-кишечных расстройств или поддержания здорового состояния желудочно-кишечного тракта с ее помощью (варианты) и упаковка, ее содержащая
CL2015002721A1 (es) Formulaciones oftálmicas
RU2016131454A (ru) Применения витамина d и его композиций для антибиоза
RU2015103115A (ru) Применение тиосульфата для усиления антипатогенного действия лактобацилл
WO2011145851A3 (ko) 사이프러스 에센셜 복합 오일을 유효 성분으로 함유하는 기억력 증진 및 인지 기능 장애 개선을 위한 화장료 조성물
GR1009632B (el) Διατροφικο συμπληρωμα για την απο του στοματος χορηγηση συνδυασμου λακτοφερινης, ξυλογλυκανης, προανθοκυανιδινων και σιμεθικονης, χρησιμων για την προληψη λοιμωξεων του γαστρεντερικου και ουροποιητικου συστηματος
MX2014009660A (es) Formulacion de anticuerpo anti-selectina p.
EA202092418A1 (ru) Композиция кремниевой кислоты и ее применение
EA201200754A1 (ru) Традиционное китайское лекарственное средство, содержащее экстракты дан-шен (danshen) и сан-ки (sanqi), и его применение
WO2005044228A3 (en) Compositions comprising cyclohexylamines and aminoadamantanes
RU2013104950A (ru) Натуральный лекарственный состав
MX2014008375A (es) Formulaciones pedriaticas de supspension oral de amoxicilina y clauvulanato de potasio y metodo para su uso.
ZA202200335B (en) Pharmaceutical composition of temozolomide.
MX2018010858A (es) Particulas de liberacion de farmacos.
EP2749288A3 (en) Capsule and composition comprising seed oil
MA40215A (fr) Compositions et méthodes permettant de prévenir les infections
MY181059A (en) Pharmaceutical composition including 5-{4 (aminosulfonyl)phenyl}-2,2-dimethyl-4-(3-fluorophenyl)-3(2h)-furanone and capsule formulation including the pharmaceutical composition

Legal Events

Date Code Title Description
PG Patent granted

Effective date: 20191128